tetano
Editor, Senior Moderator
J Thorac Oncol. 2020 Apr 27. pii: S1556-0864(20)30330-0. doi: 10.1016/j.jtho.2020.04.015. [Epub ahead of print]
SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.
Cafarotti S[SUP]1[/SUP].
Author information
Abstract
The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection.
Copyright ? 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
PMID:32353597DOI:10.1016/j.jtho.2020.04.015
SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.
Cafarotti S[SUP]1[/SUP].
Author information
Abstract
The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection.
Copyright ? 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
PMID:32353597DOI:10.1016/j.jtho.2020.04.015